abstract |
The present invention provides a live attenuated coronavirus comprising a mutation in the nonstructural protein nsp-3 and/or a deletion of the accessory proteins 3a and 3b. A coronavirus can be used as a vaccine for the treatment and/or prevention of a disease, such as infectious bronchitis, in a subject. |